ClinConnect ClinConnect Logo
Search / Trial NCT06093464

Beneficial Exposome Study

Launched by STANFORD UNIVERSITY · Oct 16, 2023

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

ClinConnect Summary

The Beneficial Exposome Study is a research project that aims to understand how regular exposure to natural compounds might help improve our overall health. These compounds are found in everyday plants and could have positive effects on our bodies. By studying how these substances influence health, researchers hope to uncover new ways to promote wellness.

To join this study, participants need to be at least 18 years old, able to read and understand English, and currently living in the U.S. However, certain individuals cannot participate, such as those who are pregnant, breastfeeding, or have specific health conditions like epilepsy or allergies to certain plants. If you decide to take part, you can expect to help researchers learn more about the benefits of these natural compounds and how they affect our health. This study is currently looking for volunteers, so it’s a great opportunity to contribute to important health research!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18 years of age and older
  • Read, speak, and understand English
  • Live in the US territory
  • Exclusion Criteria:
  • Mental incapacity and/or cognitive impairment on the part of the patient that would preclude adequate understanding of, or cooperation with, the study protocol
  • Is pregnant
  • Is breastfeeding
  • Has epilepsy
  • Has allergies to Cupressaceae family of plants, common plants include redwoods, junipers, cypress, cedar, fir, and sequoia

About Stanford University

Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.

Locations

Palo Alto, California, United States

Patients applied

0 patients applied

Trial Officials

Michael Snyder, PhD

Principal Investigator

Stanford University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported